Biomea Fusion Inc
NASDAQ:BMEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomea Fusion Inc
NASDAQ:BMEA
|
US |
|
FirstRand Ltd
F:FSRA
|
ZA |
|
C
|
Carrefour SA
BMV:CAN
|
FR |
|
U
|
UEM Sunrise Bhd
KLSE:UEMS
|
MY |
|
M
|
Maersk Drilling A/S
F:72D
|
DK |
|
Orell Fuessli AG
SIX:OFN
|
CH |
|
A
|
AstraZeneca PLC
XBER:ZEG
|
UK |
|
I
|
Intron Technology Holdings Ltd
HKEX:1760
|
HK |
|
I
|
Innovative Industrial Properties Inc
F:1IK
|
US |
|
H
|
Homology Medicines Inc
XBER:35H
|
US |
|
PCI- PAL PLC
LSE:PCIP
|
UK |
|
A
|
Acadia Realty Trust
F:WX1
|
US |
|
W
|
Williams Companies Inc
LSE:0LXB
|
US |
|
Seagate Technology Holdings PLC
NASDAQ:STX
|
IE |
|
Bell Food Group AG
F:BWGA
|
CH |
|
U
|
Unilever PLC
XHAM:UNVB
|
UK |
|
M
|
Murphy Usa Inc
XBER:1MU
|
US |
Balance Sheet
Balance Sheet Decomposition
Biomea Fusion Inc
Biomea Fusion Inc
Balance Sheet
Biomea Fusion Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
62
|
146
|
112
|
177
|
58
|
56
|
|
| Cash Equivalents |
0
|
62
|
146
|
112
|
177
|
58
|
56
|
|
| Short-Term Investments |
0
|
0
|
28
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
3
|
5
|
2
|
10
|
2
|
|
| Total Current Assets |
0
|
62
|
177
|
118
|
179
|
68
|
58
|
|
| PP&E Net |
0
|
0
|
6
|
8
|
15
|
11
|
0
|
|
| PP&E Gross |
0
|
0
|
6
|
8
|
15
|
11
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
4
|
1
|
|
| Long-Term Investments |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
4
|
6
|
1
|
0
|
|
| Total Assets |
0
N/A
|
63
+20 733%
|
186
+197%
|
129
-30%
|
200
+55%
|
80
-60%
|
59
-27%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
1
|
7
|
7
|
13
|
3
|
|
| Accrued Liabilities |
0
|
1
|
3
|
12
|
16
|
9
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
5
|
19
|
23
|
22
|
11
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
2
|
2
|
8
|
7
|
18
|
|
| Total Liabilities |
0
N/A
|
2
+433%
|
7
+331%
|
21
+201%
|
31
+48%
|
28
-8%
|
29
+2%
|
|
| Equity | ||||||||
| Common Stock |
0
|
56
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
8
|
50
|
132
|
249
|
387
|
449
|
|
| Additional Paid In Capital |
3
|
13
|
229
|
240
|
418
|
439
|
479
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
61
N/A
|
179
+194%
|
109
-39%
|
169
+56%
|
52
-70%
|
30
-43%
|
|
| Total Liabilities & Equity |
0
N/A
|
63
+20 733%
|
186
+197%
|
129
-30%
|
200
+55%
|
80
-60%
|
59
-27%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
29
|
29
|
29
|
30
|
36
|
36
|
72
|
|